Australia markets open in 8 hours 47 minutes

Apontis Pharma AG (APPH.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
8.56+0.08 (+0.94%)
As of 10:20AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 69.53M
Enterprise value 48.73M
Trailing P/E 24.14
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.95
Price/book (mrq)2.38
Enterprise value/revenue 1.32
Enterprise value/EBITDA 9.13

Trading information

Stock price history

Beta (5Y monthly) 1.69
52-week change 312.17%
S&P500 52-week change 325.22%
52-week high 39.64
52-week low 33.03
50-day moving average 38.53
200-day moving average 35.76

Share statistics

Avg vol (3-month) 36.89k
Avg vol (10-day) 36.07k
Shares outstanding 58.5M
Implied shares outstanding 68.69M
Float 84.51M
% held by insiders 10.00%
% held by institutions 118.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -30.58%
Operating margin (ttm)-25.97%

Management effectiveness

Return on assets (ttm)-10.23%
Return on equity (ttm)-31.47%

Income statement

Revenue (ttm)36.96M
Revenue per share (ttm)4.44
Quarterly revenue growth (yoy)-33.90%
Gross profit (ttm)N/A
EBITDA -7.71M
Net income avi to common (ttm)-11.3M
Diluted EPS (ttm)-1.33
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.82M
Total cash per share (mrq)3.22
Total debt (mrq)6.02M
Total debt/equity (mrq)19.89%
Current ratio (mrq)1.51
Book value per share (mrq)3.63

Cash flow statement

Operating cash flow (ttm)-12.6M
Levered free cash flow (ttm)-6.43M